Abstract
Background: We carried out a technical evaluation of the Immunodiagnostic Systems (IDS) automated intact procollagen-I N-terminus propeptide (PINP) assay on the iSYS platform, and established reference intervals for PINP in both adults and children.
Methods: Assay imprecision, recovery and interference were studied. Serum and plasma values were compared, and PINP stability was assessed. Using 828 specimens, IDS iSYS intact PINP and Roche E170 total PINP values were compared. Specimens from 597 adults and 485 children and adolescents were used to establish reference intervals for intact PINP.
Results: The method demonstrated good recovery and acceptable imprecision. The assay was unaffected by icterus and lipaemia, but haemolysis decreased measured PINP. Serum and plasma values were comparable. There was a non-linear relation between IDS intact and Roche total PINP values. Pre- and post-menopausal women had comparable PINP values, but there was a difference between women of different age groups. Serum PINP in men showed a decline in young age up to 45 years, but remained steady thereafter. Separate reference intervals were established for four age groups in women and for two age groups in men. Data for children were partitioned into four-year age groups, and these showed PINP to be high with no major gender differences until 12 years of age. Thereafter, values in females decreased in 13–16 years age groups and further in 17–20 years age groups, whereas PINP increased in boys of 13–16 years of age with a subsequent decline at 17–20 years.
Conclusions: The IDS iSYS PINP intact assay appears to be reliable. We have established gender- and age-related reference intervals for children and adults based on a relatively large healthy North European population.
IDS provided free-of-charge some of the iSYS PINP reagents that were used for assay evaluations in Oxford.
Conflict of interest statement
Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
References
1. Matsuo K, Irie N. Osteoclast-osteoblast communication. Arch Biochem Biophys 2008;473:201–9.10.1016/j.abb.2008.03.027Search in Google Scholar PubMed
2. Funck-Brentano T, Biver E, Chopin F, Bouvard B, Coiffier G, Souberbielle JC, et al. Clinical utility of serum bone turnover markers in postmenopausal osteoporosis therapy monitoring: a systematic review. Semin Arthritis Rheum 2011;41:157–69.10.1016/j.semarthrit.2011.01.005http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000296939400007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed
3. Vasikaran S, Cooper C, Eastell R, Griesmacher A, Morris HA, Trenti T, et al. International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis. Clin Chem Lab Med 2011;49:1271–4.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000293561900005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1515/CCLM.2011.602Search in Google Scholar PubMed
4. Risteli J, Risteli I. Products of bone collagen metabolism. In: Seibel MJ, Robes SP, Bilizikian RJ, editors. Dynamics of bone and cartilage metabolism: principles and clinical applications, 2nd ed., chapter 23. San Diego, USA: Academic Press, 2006:391–405.Search in Google Scholar
5. Koivula MK, Ruotsalainen V, Bjorkman M, Nurmenniemi S, Ikaheimo R, Savolainen K, et al. Difference between total and intact assays for N-terminal propetide of type 1 procollagen reflects degradation of pN-collagen rather than denaturation of intact propeptide. Ann Clin Biochem 2010;47:67–71.10.1258/acb.2009.009110http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000275482400012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed
6. Garnero P, Vergnaud P, Hoyle N. Evaluation of a fully automated serum assay for total N-terminal propeptide of type 1 collagen in post menopausal osteoporosis. Clin Chem 2008;54:188–96.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000252295600028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1373/clinchem.2007.094953Search in Google Scholar PubMed
7. Koivula M-K, Richardson J, Leino A, Valleala H, Griffiths K, Barnes A, et al. Validation of an automated intact N-terminal propeptide of type I procollagen (PINP) assay. Clin Biochem 2010;18:1453–7.10.1016/j.clinbiochem.2010.09.019http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000284520200015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed
8. Cluse ZN, Fudge AN, Whiting MJ, McWhinney B, Parkinson I, O’Loughlin PD. Evaluation of 25-hydroxy vitamin D assay on immunodiagnostic systems iSYS analyser. Ann Clin Biochem 2012;49:159–65.10.1258/acb.2011.011018http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000302050600008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed
9. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem 1983;21:709–20.10.1515/cclm.1983.21.11.709Search in Google Scholar PubMed
10. Lomeo A, Bolner A. Stability of several biochemical markers of bone metabolism. Clin Chem 2000;46:1200–2.10.1093/clinchem/46.8.1200Search in Google Scholar PubMed
11. Brandt J, Krogh TN, Jensen CH, Frederiksen JK, Teisner B. Thermal instability of the trimeric structure of the N-terminal propeptide of human procollagen type I in relation to assay technology. Clin Chem 1999;45:47–53.10.1093/clinchem/45.1.47Search in Google Scholar
12. Melkko J, Kauppila S, Niema S, Risteli L, Haukipuro K, Jukkola A, et al. Immunoassay of intact amino-terminal propeptide of human type 1 procollagen. Clin Chem 1996;42:947–54.10.1093/clinchem/42.6.947Search in Google Scholar PubMed
13. Marin L, Koivula M-K, Jukkola-Vuorinen A, Leino A, Risteli J. Comparison of total and intact aminoterminal propeptide of type I procollagen assays in patients with breast cancer with or without bone metastases. Ann Clin Biochem 2011;48:447–51.10.1258/acb.2011.011040http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000295903200007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed
14. Jukkola A, Tähtelä, R, Thölix E, Vuorinen K, Blanco G, Risteli L, et al. Aggressive breast cancer leads to discrepant serum levels of the type I procollagen propeptides PINP and PICP. Cancer Res 1997;57:5517–20.Search in Google Scholar PubMed
15. Pollmann D, Siepmann S, Geppert R, Wernecke K-D, Possinger K, Lüftner D. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer. Anticancer Res 2007;27:1853–62.Search in Google Scholar PubMed
16. Martínez J, Olmos JM, Hernández JL, Pinedo G, Llorca J, Obregón E, et al. Bone turnover markers in Spanish postmenopausal women. The Camargo cohort study. Clin Chim Acta 2009;409:70–4.10.1016/j.cca.2009.08.020http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000271563600014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed
17. Olmos JM, Hernández JL, Martínez J, Pariente E, Llorca J, González-Macías J. Bone turnover markers in Spanish adult men. The Camargo Cohort Study. Clin Chim Acta 2010;411:1511–5.10.1016/j.cca.2010.06.010http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000280906800020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed
18. Adami S, Bianchi G, Brandi ML, Giannini S, Ortolani S, DiMunno O, et al. Determinants of bone turnover markers in healthy premenopausal women. Calcif Tissue Int 2008;82:341–7.10.1007/s00223-008-9126-5Search in Google Scholar PubMed
19. Glover SJ, Garneo P, Naylor K, Rogers A, Eastell R. Establishing a reference range for bone turnover markers in young, healthy women. Bone 2008;42:623–30.10.1016/j.bone.2007.12.218Search in Google Scholar PubMed
20. Pi YZ, Wu XP, Liu SP, Luo XH, Cao XZ, Xie H, et al. Age-related changes in bone biochemical markers and their relationship with bone mineral density in normal Chinese women. J Bone Miner Metab 2006;24:380–5.10.1007/s00774-006-0703-2Search in Google Scholar PubMed
21. Glover S, Gall M, Schoenborn-Kellenberger O, Wagener M, Garnero P, Boonen S, et al. Establishing a reference interval for bone turnover markers in 637 healthy, young, premenopausal women from the United Kingdom, France, Belgium, and the United States. J Bone Min Res 2009;24:389–97.10.1359/jbmr.080703Search in Google Scholar
22. Sharp CA, Evans SF, Risteli L, Risteli J, Worsfold M, Davie MW. Effects of low- and conventional-dose transcutaneous HRT over 2 years on bone metabolism in younger and older postmenopausal women. Eur J Clin Invest 1996;26:763–71.10.1046/j.1365-2362.1996.2000550.xSearch in Google Scholar
23. Peris P, Alvarez L, Monegal A, Guañabens N, Durán M, Pons F, et al. Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy. Bone 1999;25:349–53.10.1016/S8756-3282(99)00175-1Search in Google Scholar PubMed
24. de Papp AE, Bone HG, Caulfield MP, Kagan R, Buinewicz A, Chen E, et al. A cross-sectional study of bone turnover markers in healthy premenopausal women. Bone 2007;40:1222–30.10.1016/j.bone.2007.01.008Search in Google Scholar PubMed
25. Recker R, Lappe J, Davies KM, Heaney R. Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients. J Bone Miner Res 2004;19:1628–33.10.1359/JBMR.040710Search in Google Scholar PubMed
26. Leder BZ, LeBlanc KM, Schoenfeld DA, Eastell R, Finkelstein JS. Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab 2003;88:204–10.10.1210/jc.2002-021036Search in Google Scholar PubMed
27. Szulc P, Claustrat B, Marchand F, Delmas PD. Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: the MINOS study. J Clin Endocrinol Metab 2003;88:5240–7.10.1210/jc.2003-030200Search in Google Scholar PubMed
28. Välimäki VV, Alfthan H, Ivaska KK, Löyttyniemi E, Pettersson K, Stenman UH, et al. Serum estradiol, testosterone, and sex hormone-binding globulin as regulators of peak bone mass and bone turnover rate in young Finnish men. J Clin Endocrinol Metab 2004;89:3785–9.10.1210/jc.2003-032187Search in Google Scholar PubMed
29. Crofton PM, Evans M, Taylo MR, Holland CV. Procollagen type I amino-terminal propeptide: pediatric reference data and relationship with procollagen type I carboxy-terminal propeptide. Clin Chem 2004;50:2173–6.10.1373/clinchem.2004.039958Search in Google Scholar PubMed
30. Rauchenzauner M, Schmid A, Heinz-Erian P, Kapelari K, Falkensammer G, Griesmacher A, et al. Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years. J Clin Endocrinol Metab 2007;92:443–9.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000244064900015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1210/jc.2006-1706Search in Google Scholar PubMed
©2013 by Walter de Gruyter Berlin Boston
